Drugs / Ketanserin
Ketanserin
also known as
KETANSERIN TARTRATE · Ketanserina · Ketanserine · KJK 945 · NSC-758959 · Perketan · R 49945 · R-41,468 · +2 more
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03321136 | Nov 2017 → Jul 2019 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 13 trials | ||||||
| Phase 1 | NCT06796361 | Apr 2025 → Aug 2026 overdue | — | University Hospital, Basel, Switzerland | Recruiting | No outcome recorded |
| Phase 1 | NCT04558294 | Oct 2020 → Aug 2021 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 1 | NCT03289949 | Mar 2017 → Jun 2030 expected | — | Gitte Moos Knudsen | Recruiting | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT01329887 | Mar 2011 → May 2014 | infectious disease with sepsis | Frisius Medisch Centrum | Completed | No outcome recorded |
| Phase 3 | NCT00557219 | Apr 2008 → Apr 2015 | acute kidney injury | Medical University of Gdansk | Terminated | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03646318 | Sep 2018 → Apr 2019 | — | Onze Lieve Vrouwe Gasthuis | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02451072 | Mar 2015 → Jan 2016 | — | Psychiatric University Hospital, Zurich | Completed | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 1 | NCT06899334 Background | Apr 2025 → Aug 2026 overdue | — | University Hospital, Basel, Switzerland | Recruiting | No outcome recorded |
| Phase 1 | NCT05964647 Comparator | Feb 2024 → Jun 2025 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 1 | NCT04849013 Comparator | Aug 2021 → Mar 2023 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 1/2 | NCT02632877 Comparator | Jan 2014 → Nov 2015 | ulcer of lower limbs | University of Guadalajara | Completed | No outcome recorded |
Evidence & citations 14 cited values
Every value below carries the sentence it was read from. 14 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ketanserin | “A moderate to high oral dose of 150 µg LSD will be administered followed by 20 mg intravenous ketanserin after 3 h” NCT06899334 ↗11“0.2 mg LSD plus 40 mg ketanserin per os, single doses each” NCT03321136 ↗ |
| Known as | KETANSERIN TARTRATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL51 ↗ |
| Known as | Ketanserina | ChEMBL registry synonym — accepted as the source's own label CHEMBL51 ↗ |
| Known as | Ketanserine | ChEMBL registry synonym — accepted as the source's own label CHEMBL51 ↗ |
| Known as | KJK 945 | ChEMBL registry synonym — accepted as the source's own label CHEMBL51 ↗ |
| Known as | NSC-758959 | ChEMBL registry synonym — accepted as the source's own label CHEMBL51 ↗ |
| Known as | Perketan | ChEMBL registry synonym — accepted as the source's own label CHEMBL51 ↗ |
| Known as | R 49945 | ChEMBL registry synonym — accepted as the source's own label CHEMBL51 ↗ |
| Known as | R-41,468 | ChEMBL registry synonym — accepted as the source's own label CHEMBL51 ↗ |
| Known as | Serepress | ChEMBL registry synonym — accepted as the source's own label CHEMBL51 ↗ |
| Known as | Sufrexal | “ketanserin (Sufrexal)” NCT00557219 ↗ |
| Action | Inhibit | “Ketanserin blocks a protein called the serotonin 2A receptor” PMID 30355445 ↗ Oct 2018 |
| Modality | Small molecule | — CHEMBL51 ↗ |
| Route | Intravenous | “continuous intravenous infusion 0.1 mg/kg/hour ketanserin for 24 hours” NCT00557219 ↗ |